EBV-related lymphoma after long-term daratumumab treatment: a case report

Blood Cancer J. 2020 Nov 4;10(11):113. doi: 10.1038/s41408-020-00379-y.

Authors

Ilse P G Verpoorte-Botden^{1

2}, Monique C Minnema³, Reinier A P Raymakers³

Affiliations

¹ Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands. ipgverpoorte@gmail.com.
² Department of Internal Medicine, Ziekenhuis Rivierenland Tiel, Tiel, The Netherlands. ipgverpoorte@gmail.com.
³ Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.

No abstract available

Publication types

Letter

MeSH terms

Aged
Antibodies, Monoclonal / administration & dosage
Antibodies, Monoclonal / adverse effects*
Epstein-Barr Virus Infections / chemically induced*
Epstein-Barr Virus Infections / virology
Herpesvirus 4, Human*
Humans
Lymphoma / chemically induced*
Lymphoma / virology
Male

Substances

Antibodies, Monoclonal
daratumumab